JENNIFER ADLER: Open Payments
NPI 1083181499 · WAYNESBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,821 in 93 payments from 15 companies in 2025. Trend: 2023 $283 · 2024 $523 · 2025 $1,821
Food & beverage: $1,821
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $418 |
| ABBVIE INC. | 19 | $252 |
| Phathom Pharmaceuticals, Inc. | 14 | $207 |
| AstraZeneca Pharmaceuticals LP | 9 | $182 |
| Novo Nordisk Inc | 8 | $152 |
| Astellas Pharma US Inc | 7 | $144 |
| Lilly USA, LLC | 6 | $117 |
| Amgen Inc. | 5 | $87 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| PFIZER INC. | 3 | $55 |
Products named: Kerendia, VOQUEZNA, Veozah, UBRELVY, MOUNJARO, OTEZLA, FARXIGA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
